Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1623 1673 1693 1773
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18331536 | Novel Synthesis of Phosphorodithioate Oligonucleotides | Non-Final OA | Hoffmann-La Roche Inc. |
| 18150553 | Process for the preparation of oligonucleotides using modified oxidation protocol | Non-Final OA | Hoffmann-La Roche Inc. |
| 18317282 | OSCILLATING FLUIDIZED BED OLIGONUCLEOTIDE SYNTHESIZER | Non-Final OA | Eli Lilly and Company |
| 18673752 | METHODS OF MODIFYING CELLULOSE CRYSTALLINITY | Non-Final OA | Rowan University |
| 18555206 | PROCESS FOR PRODUCING 1,1-GPM- AND/OR 1,6-GPS-ENRICHED ISOMALT COMPOSITIONS | Non-Final OA | SÜDZUCKER AG |
| 18614126 | KIT FOR PREVENTING OR TREATING FILOVIRUS AND FLAVIVIRUS DISEASES | Final Rejection | HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF HEALTH |
| 18598608 | MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION | Non-Final OA | MEDIZINISCHE UNIVERSITAT WIEN |
| 18421551 | DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS | Final Rejection | SYNEDGEN, INC. |
| 18482334 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN FELINES | Non-Final OA | Boehringer Ingelheim Vetmedica GmbH |
| 18379047 | VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18250728 | METHOD FOR PURIFYING SUCRALOSE | Non-Final OA | ANHUI JINHE INDUSTRIAL CO., LTD. |
| 18253431 | Process for the treatment of biomass | Non-Final OA | Politecnico di Milano |
| 18555180 | FLUORESCENT NUCLEOSIDE PHOSPHATES | Non-Final OA | STEALTH LABELS BIOTECH AB |
| 18484831 | COMPOSITION FOR EXTERNAL USE ON SKIN FOR INFLAMMATORY DISEASES | Non-Final OA | NIPPON SUISAN KAISHA, LTD. |
| 18285600 | NOVEL POLYPHENOL COMPOUND | Non-Final OA | NABOCUL COSMETICS CO., LTD. |
| 18353269 | OLIGONUCLEOTIDE AND NUCLEIC ACID SYNTHESIS | Non-Final OA | EVONETIX LTD |
| 18261576 | METHODS AND COMPOSITIONS FOR INCREASING NAD+ METABOLOME IN HEALTHY MIDDLE-AGED POPULATION | Non-Final OA | Bioenergy Life Science, Inc. |
| 18351905 | MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS | Non-Final OA | Cardinal Health 414, LLC |
| 18148023 | METHODS FOR THE CONJUGATION OF ANTHRACYCLINES TO CARBOHYDRATE POLYMERIC CARRIERS | Non-Final OA | Cardinal Health 414, LLC |
| 17793516 | USE OF ANTI-AGING GLYCOPEPTIDES FOR INHIBITION OF IMMUNE REJECTION OF A GRAFT | Non-Final OA | PROTOKINETIX INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy